Status:
RECRUITING
Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Cervical Dysplasia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Cervical dysplasia is the precursor of cervical cancer. LEEP and LLETZ are standard surgical procedures to treat cervical dysplasia. There is no direct head-to-head comparison between LEEP and LLETZ i...
Detailed Description
Cervical cancer is one of the most common cancers in women and one of the leading causes of death in women worldwide. Pre-cancerous lesions (dysplasias) are detected by the preventive smear test at th...
Eligibility Criteria
Inclusion
- Histologically confirmed High Grade Squamous Intraepithelial Lesion (HSIL)
- Colposcopically visible lesion
- No therapy of the disease so far
Exclusion
- Pregnancy of the patient at/after inclusion in the study; pregnancy after conization and before the control after 6 months is possible and does not lead to exclusion from the study.
- Taking immunosuppressive drugs (incl. glucocorticoids)
- Known HIV positivity
- Malignant disease requiring treatment
- Unsatisfactory colposcopy
Key Trial Info
Start Date :
June 7 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
206 Patients enrolled
Trial Details
Trial ID
NCT04772937
Start Date
June 7 2021
End Date
November 1 2025
Last Update
January 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. OBGYN Ruhr University Bochum
Herne, Germany, 44625